Current Report · Items 1.01, 2.03, 3.02, 9.01 · 8-K
American Picture House Corporation
APHPOTCEQUITYCurrent
Entry into a Material Definitive Agreement · Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement · Unregistered Sales of Equity Securities
Item 1.01 Entry into a Material Definitive Agreement. On January 20, 2026, American Picture House Corporation, a Wyoming corporation (the “Company”), entered into a Securities Purchase Agreement (the “SPA”) with Labrys Fund II, LP (“Labrys”), pursuant to which the Company issued to Labrys a 10% Promissory Note in the original principal amount of $172,500 (the “Note”), which included an original is…
Company context
Current securities
Historical securities (1)
Recent company filings
Disclosure sections
Item 1.01Item 1.01 - Entry into Material Agreement
Item
1.01 Entry into a Material Definitive Agreement.
On
January 20, 2026, American Picture House Corporation, a Wyoming corporation (the “Company”), entered into a Securities Purchase
Agreement (the “SPA”) with Labrys Fund II, LP (“Labrys”), pursuant to which the Company issued to Labrys a 10%
Promissory Note in the original principal amount of $172,500 (the “Note”), which included an original issue discount of $22,500,
in exchange for a purchase price of $150,000.
The
Note matures twelve months from the issue date and bears interest at a rate of 10% per annum. The Note is convertible into shares of
the Company’s common stock in accordance with its terms and limitations, including a conversion price based on a discount to certain
market prices over a specified trading-day lookback period and subject to beneficial ownership limitations. As additional consideration
in connection with the SPA, the Company agreed to issue 200,000 shares of its common stock to Labrys as commitment shares.
The
purchase price under the SPA was disbursed as follows: (i) $114,000 was wired to the Company, (ii) $7,500 was paid to Enclave Capital
LLC as placement agent compensation for the Company’s benefit, (iii) $25,000 was directed to Labrys for repayment of a portion
of a prior promissory note, and (iv) $3,500 was withheld for Labrys’ legal fees. In connection with the Note, the Company also
authorized its transfer agent to reserve an initial 12,000,000 shares of common stock for potential issuance upon conversion of the Note,
subject to adjustment from time to time in accordance with the terms of the Note.
The
foregoing descriptions of the SPA and the Note do not purport to be complete and are qualified in their entirety by reference to the
full text of such agreements and instruments, copies of which are filed as exhibits to this Current Report on Form 8-K and are incorporated
herein by reference.
Item 2.03Item 2.03 - Creation of Direct Financial Obligation
Item
2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.
The
information set forth above under Item 1.01 relating to the SPA and the Note is incorporated herein by reference. The Note constitutes
a direct financial obligation of the Company.
Item 3.02Item 3.02 - Unregistered Sales of Equity
Item
3.02 Unregistered Sales of Equity Securities.
As
described in Item 1.01 above, on January 20, 2026, in connection with the SPA, the Company agreed to issue 200,000 shares of its common
stock to Labrys as commitment shares. In addition, in connection with the Note, the Company authorized the reservation of an initial
12,000,000 shares of common stock for potential issuance upon conversion of the Note, subject to adjustment in accordance with the terms
of the Note.
The
securities described in this Item 3.02 were or will be issued in transactions exempt from registration under the Securities Act of 1933,
as amended (the “Securities Act”), in reliance on Section 4(a)(2) of the Securities Act and/or Rule 506 of Regulation D promulgated
thereunder, as transactions not involving any public offering. The recipient represented investment intent and appropriate restrictive
legends will be affixed to certificates or book-entry statements representing such securities, as applicable.